(Q34484831)

2 August 2017

title

The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix (English)

1 reference

2 August 2017

1 reference

Subir Nag

1

1 reference

2 August 2017

Clifford Chao

2

1 reference

2 August 2017

Beth Erickson

3

1 reference

2 August 2017

Jeffery Fowler

4

1 reference

2 August 2017

Nilendu Gupta

5

1 reference

2 August 2017

Alvaro Martinez

6

1 reference

2 August 2017

Bruce Thomadsen

7

1 reference

2 August 2017

American Brachytherapy Society

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

International Journal of Radiation Oncology Biology Physics

2 August 2017

published in

1 reference

2 August 2017

volume

52

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

33-48

1 reference

Dose equivalence for high-dose-rate to low-dose-rate intracavitary irradiation in the treatment of cancer of the uterine cervix

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

High and Low Dose-rate Brachytherapy for Cervical Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Carcinoma of the cervix, stage III. Results of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Dose and volume specification for reporting gynaecological brachytherapy: time for a change

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

New gynecologic cancer staging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Microinvasive carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Stage IA carcinoma of the cervix revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiotherapy alone for medically inoperable carcinoma of the cervix: stage IA and carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Surgical predictors of para-aortic metastases in early-stage cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafascial hysterectomy beneficial?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Carcinoma of the intact uterine cervix, stage IB-IIA-B, greater than or equal to 6 cm in diameter: irradiation alone vs preoperative irradiation and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Bulky endocervical carcinoma: a 23-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Chemoradiation and adjuvant chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Patterns of care outcome studies. Results of the national practice in cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Carcinoma of the cervix: Patterns of care studies: Review of 1978, 1983, and 1988–1989 surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The adverse effect of treatment prolongation in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Uterosacral space involvement in locally advanced carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Dose-volume analysis and the prevention of radiation sequelae in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Treatment of cancer of the cervix uteri, a revised Manchester method

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Three-dimensional applicator system for carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

PELVIC LYMPHNODECTOMY FOLLOWING RADIATION IN CERVICAL CARCINOMA

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiotherapy following simple hysterectomy in patients with stage I and II carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiotherapy of carcinoma of the cervix following simple hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Interstitial therapy of perineal and gynecological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: the Harvard/Stanford experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Treatment of extensive carcinoma of the cervix with the "transperineal parametrial butterfly": a prelimary report on the revival of Waterman's approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The Syed-Neblett interstitial template in locally advanced gynecological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Treatment of cervical carcinoma employing a template for transperineal interstitial Ir192 brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Treatment of advanced cancer of the cervix with transperineal interstitial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Interstitial parametrial implants in carcinoma of the cervix stage II-B

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Integrated external and interstitial radiation therapy for primary carcinoma of the vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Re-irradiation with interstitial implant for recurrent pelvic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

CT-guided interstitial implantation of gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Continuous postoperative epidural analgesia for gynecologic oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

The use of fluoroscopy to guide needle placement in interstitial gynecological brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Customized gynecologic interstitial implants: CT-based planning, dose evaluation, and optimization aided by laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Improved treatment planning for the Syed-Neblett template using endorectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: a new integrated technique for hysterectomized women with vaginal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

A CT-compatible version of the Fletcher system intracavitary applicator: clinical application and 3-dimensional treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Open magnetic resonance imaging using titanium-zirconium needles: improved accuracy for interstitial brachytherapy implants?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901755-2

7 January 2021

10.1016/S0360-3016(01)01755-2

Identifiers

DOI

1 reference

2 August 2017

1 reference